85 related articles for article (PubMed ID: 7191272)
21. The effects of estradiol on prolactin and growth hormone secretion in cultured pituitary cells from intact and ovariectomized rats.
Komolov IS; Perez-Arce JA; Fedotov VP
Endokrinologie; 1980 Jun; 75(3):278-84. PubMed ID: 7428709
[TBL] [Abstract][Full Text] [Related]
22. Induction of oestrus and ovulation with an ergoline derivative, substance VUFB 6638, an inhibitor of prolaction secretion.
Ausková M; Rezábek K; Zikán V; Semonský M
Physiol Bohemoslov; 1974; 23(5):417-21. PubMed ID: 4278534
[No Abstract] [Full Text] [Related]
23. Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats.
Wachtel H; Dorow R; Sauer G
Life Sci; 1984 Oct; 35(18):1859-67. PubMed ID: 6492995
[TBL] [Abstract][Full Text] [Related]
24. Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver.
Hallstrom IP; Liao DZ; Assefaw-Redda Y; Ohlson LC; Sahlin L; Eneroth P; Eriksson LC; Gustafsson JA; Blanck A
Hepatology; 1996 Oct; 24(4):849-54. PubMed ID: 8855187
[TBL] [Abstract][Full Text] [Related]
25. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Markó M
Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
[TBL] [Abstract][Full Text] [Related]
26. Ergoline congeners as potential inhibitors of prolactin release. 2.
Rusterholz DB; Barfknecht CF; Clemens JA
J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
[TBL] [Abstract][Full Text] [Related]
27. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
28. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
[TBL] [Abstract][Full Text] [Related]
29. [Blood prolactin-lowering activity of dihydroergocristine].
Cocchi D; Müller EE; Boselli P; Faini D
Farmaco Sci; 1985 Jul; 40(7):534-40. PubMed ID: 3930286
[TBL] [Abstract][Full Text] [Related]
30. Antihypertensive ergoline derivatives.
Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A
Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340
[TBL] [Abstract][Full Text] [Related]
31. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
32. [Blockade of estradiol benzoate hyperplasia of the adenohypophysis with Deprenon and lisuride - histological findings].
Dusková J; Schreiber V; Pribyl T; Jahodová J
Cesk Patol; 1983 May; 19(2):101-7. PubMed ID: 6872045
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
Cocchi D; Locatelli V; Carminati R; Müller EE
Life Sci; 1978 Sep; 23(9):927-36. PubMed ID: 703523
[No Abstract] [Full Text] [Related]
34. Fluid inhibition as a factor in estrogen-induced increase of prostatic weight in castrated rats.
Corrales JJ; Kadohama N; Chai LS; Hoisaeter PA; Hampton MT; Murphy GP; Sandberg AA
Prostate; 1981; 2(4):337-58. PubMed ID: 7329871
[TBL] [Abstract][Full Text] [Related]
35. Effect of reserpine on plasma prolactin dependent on the presence of oestrogens.
van der Gugten AA; Verhofstad F; Sala M; Kwa HG
Acta Endocrinol (Copenh); 1970 Oct; 65(2):309-15. PubMed ID: 5535987
[No Abstract] [Full Text] [Related]
36. The effect of ergocornine, bromocriptine, D-6-methyl-8-ergolinylacetamide and D-6-propyl-8-ergolinylacetamide on the prolactin secretion in goats. Comparison of potency and duration of effect.
Krejcí P; Rezábek K; Madej A; Stupnicki R; Ausková M; Bílek J
Arzneimittelforschung; 1982; 32(4):365-8. PubMed ID: 6896644
[No Abstract] [Full Text] [Related]
37. Analysis of the role of endogenous prolactin on fluid and sodium chloride absorption by the rat jejunum.
Mainoya JR
J Endocrinol; 1975 Dec; 67(3):343-9. PubMed ID: 1243144
[TBL] [Abstract][Full Text] [Related]
38. Influence of ergot derivatives on prolactin secretion in rats. Mechanisms of action and clinical implications.
Horowski R
Cephalalgia; 1983 Aug; 3 Suppl 1():131-8. PubMed ID: 6616595
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive ergolinepropionamides.
Bernardi L; Bosisio G; Mantegani S; Sapini O; Temperilli A; Salvati P; di Salle E; Arcari G; Bianchi G
Arzneimittelforschung; 1983; 33(8):1094-8. PubMed ID: 6685485
[TBL] [Abstract][Full Text] [Related]
40. Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release.
Cassady JM; Li GS; Spitzner EB; Floss HG; Clemens JA
J Med Chem; 1974 Mar; 17(3):300-7. PubMed ID: 4811225
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
